ANGPTL6 was associated with an increased risk of T2D (adjusted OR [95% CI] = 1.04 [1.01–1.08]) and obesity (adjusted OR [95% CI]= 1.03 [1.01–1.06]). Here, ANGPTL6 is linked to obesity due to melanocortin 4 receptor deficiency.